[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2640 followers Created: 2025-07-25 07:32:17 UTC $GILD European Medicines Agency grants Gilead positive CHMP opinions for twice-yearly Lenacapavir for HIV prevention under accelerated review. More Info: $XBI $IBB $XPH $PPH  XXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [$gild](/topic/$gild) [gilead sciences](/topic/gilead-sciences) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/OzmosiHealth/status/1948647479479845145)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2640 followers
Created: 2025-07-25 07:32:17 UTC
$GILD European Medicines Agency grants Gilead positive CHMP opinions for twice-yearly Lenacapavir for HIV prevention under accelerated review.
More Info: $XBI $IBB $XPH $PPH
XXX engagements
Related Topics $pph $xph $ibb $xbi more info $gild gilead sciences stocks healthcare
/post/tweet::1948647479479845145